Cytotoxicity of Mycotoxins and Their Combinations on Different Cell Lines: A Review

Paweł Skrzydlewski1, Magdalena Twarużek1, Jan Grajewski1

  • 1Department of Physiology and Toxicology, Faculty of Biological Sciences, Kazimierz Wielki University, 85-064 Bydgoszcz, Poland.

Toxins
|April 21, 2022
PubMed

Insights

Mycotoxins, toxic mold byproducts, can contaminate food during growth, harvest, or storage. Their cytotoxicity is assessed in cell lines, but these models lack complex organism interactions like immune responses.

Area of Science:

  • Food safety and toxicology
  • Mycology and microbial metabolites

Background:

  • Mycotoxins are toxic secondary metabolites produced by molds like Aspergillus, Penicillium, and Fusarium.
  • These stable compounds can form during field growth, harvest, or storage, posing significant food contamination risks.
  • Key mycotoxins of concern include aflatoxins, ochratoxin A, zearalenone, deoxynivalenol, patulin, fumonisins, and T-2/HT-2 toxins.

Purpose of the Study:

  • To review methods for assessing mycotoxin cytotoxicity.
  • To highlight the importance of evaluating mycotoxin combinations.
  • To discuss limitations of current in vitro cytotoxicity assessment models.

Main Methods:

  • Cytotoxicity is commonly evaluated using assays like MTT, neutral red, LDH, CCK-8, and ATP tests in various cell lines.
  • Apoptotic cell ratios are typically measured via flow cytometry.
  • Studies assess both individual mycotoxin toxicity and the combined effects of mycotoxin mixtures.

Main Results:

  • Mycotoxin cytotoxicity is cell line-dependent and exhibits time- and dose-dependent effects.
  • Mycotoxin combinations frequently display enhanced cytotoxicity compared to individual toxins.
  • In vitro cell line models do not fully replicate the complex interactions found in whole organisms, such as immune responses.

Conclusions:

  • Current cell-based assays provide valuable insights into mycotoxin cytotoxicity but have limitations.
  • Understanding the combined effects of mycotoxins is crucial for accurate risk assessment.
  • Future research should consider more complex models to better represent in vivo toxicological outcomes.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K